Cas:66684-60-4 1,2-Difluoro-3-methoxy-4-nitrobenzene manufacturer & supplier

Chemical Name:1,2-Difluoro-3-methoxy-4-nitrobenzene

CAS.NO:66684-60-4

Synonyms:1,2-difluoro-3-methoxy-4-nitro-benzene;2,3-DIFLUORO-6-NITROANISOLE;2,3-Difluoro-6-nitro-anisole;1,2-Difluoro-3-methoxy-4-nitrobenzene;Benzene, 1,2-difluoro-3-methoxy-4-nitro-;2,3-Difluoro-6-nitrophenyl methyl ether

Molecular Formula:C₇H₅F₂NO₃

Molecular Weight:189.116

HS Code:2909309090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:259.0±35.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.502

PSA:55.05000

Exact Mass:189.023743

LogP:1.44

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,2-difluoro-3-methoxy-4-nitro-benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-Difluoro-6-nitrophenyl methyl ether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-DIFLUORO-6-NITROANISOLE Use and application,Benzene, 1,2-difluoro-3-methoxy-4-nitro- technical grade,usp/ep/jp grade.

Related News: The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 1,2-Difluoro-3-methoxy-4-nitrobenzene manufacturer He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 1,2-Difluoro-3-methoxy-4-nitrobenzene supplier Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration. 1,2-Difluoro-3-methoxy-4-nitrobenzene vendor He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 1,2-Difluoro-3-methoxy-4-nitrobenzene factory The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).